Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
276 | 18466 | 32.6 | 76% |
Classes in level above (level 3) |
Classes in level below (level 1) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BREAST CANCER | Author keyword | 689 | 11% | 31% | 5701 |
2 | ACCELERATED PARTIAL BREAST IRRADIATION | Author keyword | 332 | 91% | 1% | 136 |
3 | PARTIAL BREAST IRRADIATION | Author keyword | 294 | 84% | 1% | 158 |
4 | BREAST CONSERVING THERAPY | Author keyword | 272 | 66% | 1% | 252 |
5 | SENTINEL LYMPH NODE BIOPSY | Author keyword | 261 | 43% | 2% | 461 |
6 | METASTATIC BREAST CANCER | Author keyword | 256 | 38% | 3% | 538 |
7 | PEGFILGRASTIM | Author keyword | 230 | 81% | 1% | 138 |
8 | SENTINEL LYMPH NODE | Author keyword | 214 | 34% | 3% | 507 |
9 | NEOADJUVANT CHEMOTHERAPY | Author keyword | 197 | 29% | 3% | 581 |
10 | BREAST CONSERVING SURGERY | Author keyword | 192 | 53% | 1% | 258 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BREAST CANCER | 689 | 11% | 31% | 5701 | Search BREAST+CANCER | Search BREAST+CANCER |
2 | ACCELERATED PARTIAL BREAST IRRADIATION | 332 | 91% | 1% | 136 | Search ACCELERATED+PARTIAL+BREAST+IRRADIATION | Search ACCELERATED+PARTIAL+BREAST+IRRADIATION |
3 | PARTIAL BREAST IRRADIATION | 294 | 84% | 1% | 158 | Search PARTIAL+BREAST+IRRADIATION | Search PARTIAL+BREAST+IRRADIATION |
4 | BREAST CONSERVING THERAPY | 272 | 66% | 1% | 252 | Search BREAST+CONSERVING+THERAPY | Search BREAST+CONSERVING+THERAPY |
5 | SENTINEL LYMPH NODE BIOPSY | 261 | 43% | 2% | 461 | Search SENTINEL+LYMPH+NODE+BIOPSY | Search SENTINEL+LYMPH+NODE+BIOPSY |
6 | METASTATIC BREAST CANCER | 256 | 38% | 3% | 538 | Search METASTATIC+BREAST+CANCER | Search METASTATIC+BREAST+CANCER |
7 | PEGFILGRASTIM | 230 | 81% | 1% | 138 | Search PEGFILGRASTIM | Search PEGFILGRASTIM |
8 | SENTINEL LYMPH NODE | 214 | 34% | 3% | 507 | Search SENTINEL+LYMPH+NODE | Search SENTINEL+LYMPH+NODE |
9 | NEOADJUVANT CHEMOTHERAPY | 197 | 29% | 3% | 581 | Search NEOADJUVANT+CHEMOTHERAPY | Search NEOADJUVANT+CHEMOTHERAPY |
10 | BREAST CONSERVING SURGERY | 192 | 53% | 1% | 258 | Search BREAST+CONSERVING+SURGERY | Search BREAST+CONSERVING+SURGERY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AXILLARY DISSECTION | 781 | 60% | 5% | 859 |
2 | CONSERVING SURGERY | 575 | 50% | 5% | 836 |
3 | LUMPECTOMY | 479 | 52% | 3% | 644 |
4 | 20 YEAR FOLLOW UP | 475 | 53% | 3% | 636 |
5 | CONSERVING THERAPY | 470 | 56% | 3% | 572 |
6 | CONSERVATIVE SURGERY | 361 | 42% | 4% | 661 |
7 | PREOPERATIVE CHEMOTHERAPY | 356 | 32% | 5% | 938 |
8 | MASTECTOMY | 346 | 29% | 5% | 991 |
9 | SINGLE ADMINISTRATION PEGFILGRASTIM | 298 | 86% | 1% | 154 |
10 | PERITUMORAL INJECTION | 269 | 95% | 0% | 91 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BREAST | 115 | 22% | 3% | 467 |
2 | BREAST CANCER RESEARCH AND TREATMENT | 79 | 11% | 4% | 708 |
3 | CLINICAL BREAST CANCER | 49 | 26% | 1% | 163 |
4 | BREAST CANCER | 45 | 29% | 1% | 132 |
5 | BREAST JOURNAL | 44 | 20% | 1% | 192 |
6 | EJSO | 26 | 11% | 1% | 232 |
7 | JOURNAL OF BREAST CANCER | 23 | 21% | 1% | 99 |
8 | BREAST CARE | 16 | 17% | 0% | 86 |
9 | MEDICAL DOSIMETRY | 7 | 11% | 0% | 61 |
10 | EJC SUPPLEMENTS | 5 | 12% | 0% | 39 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
MOLECULAR ORIGINS OF CANCER Gene-Expression Signatures in Breast Cancer | 2009 | 550 | 83 | 69% |
Triple-Negative Breast Cancer | 2010 | 454 | 57 | 61% |
American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer | 2005 | 776 | 126 | 80% |
Molecular and protein markers for clinical decision making in breast cancer: Today and tomorrow | 2014 | 20 | 90 | 84% |
Subtyping of Triple-Negative Breast Cancer: Implications for Therapy | 2015 | 5 | 41 | 49% |
Clinical application of the 70-gene profile: The MINDACT trial | 2008 | 233 | 20 | 95% |
Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic review | 2015 | 2 | 43 | 93% |
The value of multigene predictors of clinical outcome in breast cancer: an analysis of the evidence | 2015 | 2 | 57 | 93% |
Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes | 2014 | 33 | 59 | 42% |
Deconstructing the molecular portraits of breast cancer | 2011 | 234 | 81 | 41% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BREAST MED ONCOL | 115 | 28% | 1.9% | 348 |
2 | BREAST SURG | 95 | 19% | 2.4% | 448 |
3 | SENOL | 57 | 34% | 0.7% | 138 |
4 | BREAST UNIT | 48 | 21% | 1.1% | 203 |
5 | BREAST SERV | 44 | 36% | 0.5% | 98 |
6 | BREAST ONCOL | 40 | 24% | 0.8% | 142 |
7 | BEAUMONT CANC | 38 | 66% | 0.2% | 35 |
8 | BREAST ENDOCRINE SURG | 27 | 18% | 0.7% | 135 |
9 | BREAST SURG UNIT | 25 | 34% | 0.3% | 60 |
10 | UNIT MED SENOL | 24 | 50% | 0.2% | 35 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000014815 | BREAST//DUCTAL CARCINOMA IN SITU//NIPPLE DISCHARGE |
2 | 0.0000011948 | MAMMOGRAPHY//BREAST SELF EXAMINATION//BREAST CANCER SCREENING |
3 | 0.0000010287 | BREAST RECONSTRUCTION//BREAST REDUCTION//CAPSULAR CONTRACTURE |
4 | 0.0000010102 | HER 2//TRASTUZUMAB//LAPATINIB |
5 | 0.0000008939 | LYMPHEDEMA//NECROTIZING FASCIITIS//FOURNIERS GANGRENE |
6 | 0.0000008774 | TAMOXIFEN//AROMATASE INHIBITORS//ANASTROZOLE |
7 | 0.0000008178 | CHROMATIN SUPRAORGANIZATION//ZNF703//NUCLEAR PHENOTYPES |
8 | 0.0000008124 | CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY//VINFLUNINE//VINCRISTINE |
9 | 0.0000008085 | BRCA1//BRCA2//CHEK2 |
10 | 0.0000007091 | HODGKINS DISEASE//HODGKIN LYMPHOMA//HODGKINS LYMPHOMA |